PharmaCyte Going Hea
PharmaCyte Going Head to Head with Eli Lilly's Pancreatic Cancer Drug in New Clinical Trial
January 24, 2017 09:10 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - January 24, 2017) - Ten years ago the National Cancer Institute (NCI) recognized the rise in pancreatic cancer deaths and called for the development of better treatments....
Greenridge Global Is
Greenridge Global Issues Research Report with Buy Rating and $3 Price Target on Staffing 360 Solutions, Inc.
January 19, 2017 08:00 ET | Staffing 360 Solutions, Inc.
NEW YORK, NY--(Marketwired - January 19, 2017) - Staffing 360 Solutions, Inc. (NASDAQ: STAF), an international staffing services provider, announced its fiscal second quarter numbers last week, and...
Live Ventures Hits $
Live Ventures Hits $79-Million in Revenues While Company Expects to Surpass $120-Million in 2017
December 29, 2016 08:30 ET | Live Ventures Incorporated
NEW YORK, NY--(Marketwired - December 29, 2016) - Live Ventures, Inc. (NASDAQ: LIVE) released its financials for fiscal year-end (YE) 2016, and the company announced record revenues of almost...
PharmaCyte Biotech S
PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial
December 12, 2016 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - December 12, 2016) - All of the pieces are starting to fall into place for PharmaCyte Biotech (OTCQB: PMCB) and its upcoming human clinical trial in advanced pancreatic...
PharmaCyte Biotech M
PharmaCyte Biotech Moves Closer to Enrolling Patients in Pancreatic Cancer Clinical Trial
December 01, 2016 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - December 01, 2016) - PharmaCyte Biotech (OTCQB: PMCB) is now one step closer to enrolling patients in a pivotal clinic trial in advanced, inoperable pancreatic cancer...
SPYR's Role-Playing,
SPYR's Role-Playing, Strategy Game, Pocket Starships, A Part of Most Lucrative Mobile Game Genres
November 29, 2016 09:15 ET | SPYR, Inc.
NEW YORK, NY --(Marketwired - November 29, 2016) - When it comes to mobile games, SPYR, Inc.'s (OTCQB: SPYR) flagship MMO game, Pocket Starships, falls into all the right categories for revenue...
SPYR Targets Worldwi
SPYR Targets Worldwide Audience for Pocket Starships as Asian Market Continues Solid Growth
November 17, 2016 09:15 ET | SPYR, Inc.
NEW YORK, NY--(Marketwired - November 17, 2016) - In 2016, the global games market grew to almost $100 billion according to Newzoo's Global Games Market Report. In that report, China and the...
PharmaCyte Biotech N
PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial
November 16, 2016 09:15 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - November 16, 2016) - PharmaCyte Biotech (OTCQB: PMCB) has arrived at the door of U.S. FDA and awaits a pre-IND meeting with the agency. After years of surrounding its...
SPYR Executive Discu
SPYR Executive Discusses Company's Future in Mobile eSports
November 04, 2016 09:15 ET | SPYR, Inc.
NEW YORK, NY--(Marketwired - November 04, 2016) - At the end of October, SPYR, Inc. (OTCQB: SPYR) added Mike Turner, a video game industry expert, to its team as its VP of Strategic Partnerships....
SPYR Outperforming P
SPYR Outperforming Projections With Fundamental Approach to Driving Growth
October 13, 2016 09:15 ET | SPYR, Inc.
NEW YORK, NY--(Marketwired - October 13, 2016) - SPYR, Inc. (OTCQB: SPYR) has exceeded its own early projections in the company's marketing and advertising campaign for its flagship MMO game Pocket...